Ad
related to: abbvie calls off- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Search results
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 20 hours agoThe latest trading session saw AbbVie (ABBV) ending at $160.19, denoting a -0.65% adjustment from...
Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?
Zacks via Yahoo Finance· 6 days agoInvestors in AbbVie Inc. ABBV need to pay close attention to the stock based on moves in the options...
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 3 hours agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 5 days agoRob Michael, AbbVie's president and COO who's set to become CEO in July, said in the company's Q1 earnings call that AbbVie remains " ...
Earnings call: CollPlant reports Q1 2024 results and corporate updates By Investing.com
Investing.com· 6 days agoCollPlant Biotechnologies (NASDAQ: CLGN) has released its financial outcomes for the first quarter...
10 Health Care Stocks Whale Activity In Today's Session - AbbVie (NYSE:ABBV), Bristol-Myers Squibb...
Benzinga· 4 days agoAbnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. Here's the list of options activity happening in today's session: Symbol PUT/CALL ...
J&J antidepressant eases symptoms, improves sleep in key trial
BioPharma Dive via Yahoo Finance· 6 days agoDive Insight: J&J was one of the few large pharmaceutical companies to remain active in...
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Investor's Business Daily· 7 days agoLeerink Partners analyst Joseph Schwartz compared the market potential for Insmed's brensocatib to...
The Democratic Bill To Raise Drug Prices By Protecting Patent Trolls
Forbes· 7 days agoReducing prescription drug prices has long been a goal of Democrats in Congress and the White House....
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 5 days agoThe 272% surge in Summit’s stock more than doubled the fortune of pharma billionaire Robert (“Bob”)...
